#CreatineForHealth GLP-1 receptor agonists (like semaglutide and tirzepatide) are revolutionizing obesity and type 2 diabetes care, but up to 40% of weight loss may come from lean mass
Contact your GP urgently if you experience severe or persistent abdominal pain, repeated vomiting, signs of gastrointestinal bleeding (vomiting blood or black stools), symptoms of dehydration, or unexplained weight loss beyond the expected therapeutic effect
Lean, metabolically healthy profiles use roughly 0.3 to 0.5 mg because exposure and heart-rate sensitivity are higher at the same nominal dose. These sub-1 mg ranges are modeled rather than outcome-tested
If further improvement is needed after another 4 weeks, the dose can be raised to 2 mg weekly
Surprisingly, when taking BPC-157, users do not experience any nasty side effects
E., Puri, V., Lee, K